Literature DB >> 26432925

Simultaneous quantitation of hexacosanoyl lysophosphatidylcholine, amino acids, acylcarnitines, and succinylacetone during FIA-ESI-MS/MS analysis of dried blood spot extracts for newborn screening.

Christopher A Haynes1, Víctor R De Jesús2.   

Abstract

OBJECTIVES: The goal of this study was to include the quantitation of hexacosanoyl lysophosphatidylcholine, a biomarker for X-linked adrenoleukodystrophy and other peroxisomal disorders, in the routine extraction and analysis procedure used to quantitate amino acids, acylcarnitines, and succinylacetone during newborn screening. Criteria for the method included use of a single punch from a dried blood spot, one simple extraction of the punch, no high-performance liquid chromatography, and utilizing tandem mass spectrometry to quantitate the analytes. DESIGN AND METHODS: Dried blood spot punches were extracted with a methanolic solution of stable-isotope labeled internal standards, formic acid, and hydrazine, followed by flow injection analysis-electrospray ionization-tandem mass spectrometry.
RESULTS: Quantitation of amino acids, acylcarnitines, and hexacosanoyl lysophosphatidylcholine using this combined method was similar to results obtained using two separate methods.
CONCLUSIONS: A single dried blood spot punch extracted by a rapid (45min), simple procedure can be analyzed with high throughput (2min per sample) to quantitate amino acids, acylcarnitines, succinylacetone, and hexacosanoyl lysophosphatidylcholine. Published by Elsevier Inc.

Entities:  

Keywords:  Dried blood spot; Flow-injection analysis; Newborn screening; Tandem mass spectrometry; X-linked adrenoleukodystrophy

Mesh:

Substances:

Year:  2015        PMID: 26432925      PMCID: PMC4836612          DOI: 10.1016/j.clinbiochem.2015.09.011

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  16 in total

1.  Fifty years of newborn screening.

Authors:  Bridget Wilcken; Veronica Wiley
Journal:  J Paediatr Child Health       Date:  2015-01       Impact factor: 1.954

Review 2.  Expanded newborn screening and confirmatory follow-up testing for inborn errors of metabolism detected by tandem mass spectrometry.

Authors:  Tomris Ozben
Journal:  Clin Chem Lab Med       Date:  2013-01       Impact factor: 3.694

Review 3.  The use of mass spectrometry to analyze dried blood spots.

Authors:  Michel Wagner; David Tonoli; Emmanuel Varesio; Gérard Hopfgartner
Journal:  Mass Spectrom Rev       Date:  2014-09-22       Impact factor: 10.946

4.  Improved analysis of C26:0-lysophosphatidylcholine in dried-blood spots via negative ion mode HPLC-ESI-MS/MS for X-linked adrenoleukodystrophy newborn screening.

Authors:  Christopher A Haynes; Víctor R De Jesús
Journal:  Clin Chim Acta       Date:  2012-04-04       Impact factor: 3.786

5.  Improved tandem mass spectrometry (MS/MS) derivatized method for the detection of tyrosinemia type I, amino acids and acylcarnitine disorders using a single extraction process.

Authors:  Kuldeep S Dhillon; Ajit S Bhandal; Constantino P Aznar; Fred W Lorey; Partha Neogi
Journal:  Clin Chim Acta       Date:  2011-01-07       Impact factor: 3.786

6.  Streamlined determination of lysophosphatidylcholines in dried blood spots for newborn screening of X-linked adrenoleukodystrophy.

Authors:  Coleman T Turgeon; Ann B Moser; Lars Mørkrid; Mark J Magera; Dimitar K Gavrilov; Devin Oglesbee; Kimiyo Raymond; Piero Rinaldo; Dietrich Matern; Silvia Tortorelli
Journal:  Mol Genet Metab       Date:  2014-11-27       Impact factor: 4.797

7.  Newborn screening for X-linked adrenoleukodystrophy: further evidence high throughput screening is feasible.

Authors:  Christiane Theda; Katy Gibbons; Todd E Defor; Pamela K Donohue; W Christopher Golden; Antonie D Kline; Fizza Gulamali-Majid; Susan R Panny; Walter C Hubbard; Richard O Jones; Anita K Liu; Ann B Moser; Gerald V Raymond
Journal:  Mol Genet Metab       Date:  2013-11-09       Impact factor: 4.797

8.  Newborn screening for metabolic diseases: saving children's lives and improving outcomes.

Authors:  Michael J Bennett
Journal:  Clin Biochem       Date:  2014-06-02       Impact factor: 3.281

9.  Development of an assay to simultaneously measure orotic acid, amino acids, and acylcarnitines in dried blood spots.

Authors:  Patrice K Held; Christopher A Haynes; Víctor R De Jesús; Mei W Baker
Journal:  Clin Chim Acta       Date:  2014-06-02       Impact factor: 3.786

10.  Postanalytical tools improve performance of newborn screening by tandem mass spectrometry.

Authors:  Patricia L Hall; Gregg Marquardt; David M S McHugh; Robert J Currier; Hao Tang; Stephanie D Stoway; Piero Rinaldo
Journal:  Genet Med       Date:  2014-05-29       Impact factor: 8.822

View more
  9 in total

1.  Zellweger Syndrome Disorders: From Severe Neonatal Disease to Atypical Adult Presentation.

Authors:  David Cheillan
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

2.  Evaluation of C26:0-lysophosphatidylcholine and C26:0-carnitine as diagnostic markers for Zellweger spectrum disorders.

Authors:  Femke C C Klouwer; Sacha Ferdinandusse; Henk van Lenthe; Wim Kulik; Ronald J A Wanders; Bwee Tien Poll-The; Hans R Waterham; Frédéric M Vaz
Journal:  J Inherit Metab Dis       Date:  2017-07-04       Impact factor: 4.982

3.  Evaluation of X-Linked Adrenoleukodystrophy Newborn Screening in North Carolina.

Authors:  Stacey Lee; Kristin Clinard; Sarah P Young; Catherine W Rehder; Zheng Fan; Ali S Calikoglu; Deeksha S Bali; Donald B Bailey; Lisa M Gehtland; David S Millington; Hari S Patel; Sara E Beckloff; Scott J Zimmerman; Cynthia M Powell; Jennifer L Taylor
Journal:  JAMA Netw Open       Date:  2020-01-03

4.  Newborn Screen for X-Linked Adrenoleukodystrophy Using Flow Injection Tandem Mass Spectrometry in Negative Ion Mode.

Authors:  Tarek A Teber; Brian J Conti; Christopher A Haynes; Amy Hietala; Mei W Baker
Journal:  Int J Neonatal Screen       Date:  2022-04-14

5.  Laboratory diagnosis of disorders of peroxisomal biogenesis and function: a technical standard of the American College of Medical Genetics and Genomics (ACMG).

Authors:  Irene De Biase; Silvia Tortorelli; Lisa Kratz; Steven J Steinberg; Kristina Cusmano-Ozog; Nancy Braverman
Journal:  Genet Med       Date:  2019-12-11       Impact factor: 8.822

6.  Laboratory analysis of acylcarnitines, 2020 update: a technical standard of the American College of Medical Genetics and Genomics (ACMG).

Authors:  Marcus J Miller; Kristina Cusmano-Ozog; Devin Oglesbee; Sarah Young
Journal:  Genet Med       Date:  2020-10-19       Impact factor: 8.822

7.  C26:0-Carnitine Is a New Biomarker for X-Linked Adrenoleukodystrophy in Mice and Man.

Authors:  Malu-Clair van de Beek; Inge M E Dijkstra; Henk van Lenthe; Rob Ofman; Dalia Goldhaber-Pasillas; Nicolas Schauer; Martin Schackmann; Joo-Yeon Engelen-Lee; Frédéric M Vaz; Wim Kulik; Ronald J A Wanders; Marc Engelen; Stephan Kemp
Journal:  PLoS One       Date:  2016-04-28       Impact factor: 3.240

8.  A selective detection of lysophosphatidylcholine in dried blood spots for diagnosis of adrenoleukodystrophy by LC-MS/MS.

Authors:  Ryuichi Mashima; Misa Tanaka; Eri Sakai; Hidenori Nakajima; Tadayuki Kumagai; Motomichi Kosuga; Torayuki Okuyama
Journal:  Mol Genet Metab Rep       Date:  2016-03-18

Review 9.  Mass spectrometry based high-throughput bioanalysis of low molecular weight compounds: are we ready to support personalized medicine?

Authors:  Sophie Bravo-Veyrat; Gérard Hopfgartner
Journal:  Anal Bioanal Chem       Date:  2021-08-23       Impact factor: 4.142

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.